201 related articles for article (PubMed ID: 11817712)
21. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
[TBL] [Abstract][Full Text] [Related]
22. Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism.
Gingras D; Pagé M; Annabi B; Béliveau R
Biochim Biophys Acta; 2000 Sep; 1497(3):341-50. PubMed ID: 10996658
[TBL] [Abstract][Full Text] [Related]
23. MT1-MMP in rat testicular development and the control of Sertoli cell proMMP-2 activation.
Longin J; Guillaumot P; Chauvin MA; Morera AM; Le Magueresse-Battistoni B
J Cell Sci; 2001 Jun; 114(Pt 11):2125-34. PubMed ID: 11493648
[TBL] [Abstract][Full Text] [Related]
24. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
[TBL] [Abstract][Full Text] [Related]
25. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
26. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.
Hofmann UB; Westphal JR; Van Kraats AA; Ruiter DJ; Van Muijen GN
Int J Cancer; 2000 Jul; 87(1):12-9. PubMed ID: 10861447
[TBL] [Abstract][Full Text] [Related]
27. Collagen-induced proMMP-2 activation by MT1-MMP in human dermal fibroblasts and the possible role of alpha2beta1 integrins.
Zigrino P; Drescher C; Mauch C
Eur J Cell Biol; 2001 Jan; 80(1):68-77. PubMed ID: 11211937
[TBL] [Abstract][Full Text] [Related]
28. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
29. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
Jo Y; Yeon J; Kim HJ; Lee ST
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
[TBL] [Abstract][Full Text] [Related]
30. Calmodulin antagonists increase the expression of membrane-type-1 matrix metalloproteinase in human uterine cervical fibroblasts.
Ito A; Yamada M; Sato T; Sanekata K; Sato H; Seiki M; Nagase H; Mori Y
Eur J Biochem; 1998 Jan; 251(1-2):353-8. PubMed ID: 9492304
[TBL] [Abstract][Full Text] [Related]
31. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
[TBL] [Abstract][Full Text] [Related]
32. Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy.
Noda K; Ishida S; Inoue M; Obata K; Oguchi Y; Okada Y; Ikeda E
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2163-70. PubMed ID: 12714657
[TBL] [Abstract][Full Text] [Related]
33. Effects of 17beta-estradiol on the expression of matrix metalloproteinase-1, -2 and tissue inhibitor of metalloproteinase-1 in human osteoblast-like cell cultures.
Liao EY; Luo XH
Endocrine; 2001 Aug; 15(3):291-5. PubMed ID: 11762702
[TBL] [Abstract][Full Text] [Related]
34. Expression of membrane-type 1 matrix metalloproteinase in coronary vessels of allotransplanted primate hearts.
Tsukioka K; Suzuki J; Kawauchi M; Wada Y; Zhang T; Nishio A; Koide N; Endoh M; Takayama K; Takamoto S; Isobe M; Amano J
J Heart Lung Transplant; 2000 Dec; 19(12):1193-8. PubMed ID: 11124489
[TBL] [Abstract][Full Text] [Related]
35. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation.
Hernandez-Barrantes S; Toth M; Bernardo MM; Yurkova M; Gervasi DC; Raz Y; Sang QA; Fridman R
J Biol Chem; 2000 Apr; 275(16):12080-9. PubMed ID: 10766841
[TBL] [Abstract][Full Text] [Related]
36. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
37. Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium.
Zhang J; Hampton AL; Nie G; Salamonsen LA
Biol Reprod; 2000 Jan; 62(1):85-94. PubMed ID: 10611071
[TBL] [Abstract][Full Text] [Related]
38. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
Nie J; Pei D
Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
[TBL] [Abstract][Full Text] [Related]
39. Cell surface activation of progelatinase A (proMMP-2) and cell migration.
Nagase H
Cell Res; 1998 Sep; 8(3):179-86. PubMed ID: 9791731
[TBL] [Abstract][Full Text] [Related]
40. The membrane-type-matrix metalloproteinase/matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodeling in loose total-hip prostheses.
Takagi M; Santavirta S; Ida H; Ishii M; Akimoto K; Saotome K; Konttinen YT
Lab Invest; 1998 Jun; 78(6):735-42. PubMed ID: 9645764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
